» Articles » PMID: 30660105

In Silico Engineering of Synthetic Binding Proteins from Random Amino Acid Sequences

Abstract

Synthetic proteins with high affinity and selectivity for a protein target can be used as research tools, biomarkers, and pharmacological agents, but few methods exist to design such proteins de novo. To this end, the In-Silico Protein Synthesizer (InSiPS) was developed to design synthetic binding proteins (SBPs) that bind pre-determined targets while minimizing off-target interactions. InSiPS is a genetic algorithm that refines a pool of random sequences over hundreds of generations of mutation and selection to produce SBPs with pre-specified binding characteristics. As a proof of concept, we design SBPs against three yeast proteins and demonstrate binding and functional inhibition of two of three targets in vivo. Peptide SPOT arrays confirm binding sites, and a permutation array demonstrates target specificity. Our foundational approach will support the field of de novo design of small binding polypeptide motifs and has robust applicability while offering potential advantages over the limited number of techniques currently available.

Citing Articles

Future Perspective: Harnessing the Power of Artificial Intelligence in the Generation of New Peptide Drugs.

Nissan N, Allen M, Sabatino D, Biggar K Biomolecules. 2024; 14(10).

PMID: 39456236 PMC: 11505729. DOI: 10.3390/biom14101303.


Peptides of a Feather: How Computation Is Taking Peptide Therapeutics under Its Wing.

Kazmirchuk T, Bradbury-Jost C, Withey T, Gessese T, Azad T, Samanfar B Genes (Basel). 2023; 14(6).

PMID: 37372372 PMC: 10298604. DOI: 10.3390/genes14061194.


Computational Protein Design for COVID-19 Research and Emerging Therapeutics.

Kalita P, Tripathi T, Padhi A ACS Cent Sci. 2023; 9(4):602-613.

PMID: 37122454 PMC: 10042144. DOI: 10.1021/acscentsci.2c01513.


A computational approach to rapidly design peptides that detect SARS-CoV-2 surface protein S.

Hajikarimlou M, Hooshyar M, Moutaoufik M, Aly K, Azad T, Takallou S NAR Genom Bioinform. 2022; 4(3):lqac058.

PMID: 36004308 PMC: 9394169. DOI: 10.1093/nargab/lqac058.


Assessing sequence-based protein-protein interaction predictors for use in therapeutic peptide engineering.

Charih F, Biggar K, Green J Sci Rep. 2022; 12(1):9610.

PMID: 35688894 PMC: 9187631. DOI: 10.1038/s41598-022-13227-9.


References
1.
Hanway D, Chin J, Xia G, Oshiro G, Winzeler E, Romesberg F . Previously uncharacterized genes in the UV- and MMS-induced DNA damage response in yeast. Proc Natl Acad Sci U S A. 2002; 99(16):10605-10. PMC: 124988. DOI: 10.1073/pnas.152264899. View

2.
Jia C, Nie J, Wu C, Li C, Li S . Novel Src homology 3 domain-binding motifs identified from proteomic screen of a Pro-rich region. Mol Cell Proteomics. 2005; 4(8):1155-66. DOI: 10.1074/mcp.M500108-MCP200. View

3.
Chica R, Doucet N, Pelletier J . Semi-rational approaches to engineering enzyme activity: combining the benefits of directed evolution and rational design. Curr Opin Biotechnol. 2005; 16(4):378-84. DOI: 10.1016/j.copbio.2005.06.004. View

4.
Brown J, Sherlock G, Myers C, Burrows N, Deng C, Wu H . Global analysis of gene function in yeast by quantitative phenotypic profiling. Mol Syst Biol. 2006; 2:2006.0001. PMC: 1681475. DOI: 10.1038/msb4100043. View

5.
Neduva V, Russell R . Peptides mediating interaction networks: new leads at last. Curr Opin Biotechnol. 2006; 17(5):465-71. DOI: 10.1016/j.copbio.2006.08.002. View